Navigation Links
Botox Competitor Cleared to Re-Enter the Market
Date:1/20/2013

Los Angeles, CA (PRWEB) January 20, 2013

“I don’t see how this can be anything but a good thing for consumers,” opines Dr. Ourian, Medical Director of Epione Beverly Hills. “First there was Botox, then Dysport and now Xeomin, each with certain distinct attributes. This can only enable me to do a better job of serving the needs of my patients.”

The injunction, issued by a U.S. District Judge on March 9, 2012, prevented Merz USA from doing a full commercial launch of Xeomin, the wrinkle-busting drug it developed to compete against market leader Allergan’s Botox. The judge concluded that several salespeople hired away from Allergan by Merz took confidential client information and market research when they left. (go to: goo.gl/IvkbK)

“Regardless of which treatment option you choose, consumers need to be smart and safe about the doctor they choose,” says Dr. Ourian. “That why I recently created a six-point Botox checklist.”

  •     It’s important to know who is going to do the actual treatment. Will it be a physician or an RN. Do your research and ask friends and family for referrals.
  •     In California only a physician can conduct the examination and consultation required before a prescription for Botox, Dysport or Xeomin is issued.
  •     These are medical treatments and should only be done in a medical office setting.
  •     Make certain you understand the post-treatment instructions.
  •     Confirm that whatever product you choose to be injected with (Botox, Dysport or Xeomin) is the authentic product manufactured by Allergan, Medicis or Merz respectively. The U.S. Food & Drug Administration recently warned 350 medical practices about their importation of unapproved Botox from a Canadian pharmacy. (go to: goo.gl/WC3fX)
  •     Don’t be afraid to ask questions.

For more information about Botox Competitor Cleared to Re-Enter the Market click here.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10340972.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Botox Offers Little Relief for Migraine, Study Finds
2. Botox May Ease Tremors in Multiple Sclerosis Patients
3. Botox beats steroids for painful foot condition, plantar fasciitis
4. FDA Gives Nod to Botox to Treat Overactive Bladder
5. The Stone Bake Oven Company: UK Wood Fired Ovens Are Coming Up Trumps Over International Competitors
6. Passengers on Bat Plane Cleared of Rabies Risk
7. Lice Tamers Brings FDA-Cleared LouseBuster™ Device to Suffolk County
8. Majority of states fail to address youth exposure to alcohol marketing
9. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
10. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
11. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: